Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study-Reference-Cited by-同舟云学术

Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study

Published:2024-04 Issue: Volume:588 Page:216711
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Miele Evelina^ORCID,Anghileri Elena^ORCID,Calatozzolo Chiara^ORCID,Lazzarini Elisabetta^ORCID,Patrizi Sara^ORCID,Ciolfi Andrea,Pedace Lucia,Patanè Monica,Abballe Luana,Paterra Rosina^ORCID,Maddaloni Luisa^ORCID,Barresi Sabina^ORCID,Mastronuzzi Angela,Petruzzi Alessandra,Tramacere Irene,Farinotti Mariangela^ORCID,Gurrieri Lorena,Pirola Elena,Scarpelli Mauro,Lombardi Giuseppe,Villani Veronica,Simonelli Matteo^ORCID,Merli Rossella,Salmaggi Andrea,Tartaglia Marco,Silvani Antonio^ORCID,DiMeco Francesco,Calistri Daniele,Lamperti Elena,Locatelli Franco,Indraccolo Stefano,Pollo Bianca

Publisher

Elsevier BV

Reference47 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018;Ostrom;Neuro Oncol.,2021

2. Survivorship in adults with malignant brain and other central nervous system tumor from 2000–2014;Gittleman;Neuro Oncol.,2018

3. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain;Geisenberger;Acta Neuropathol.,2015

4. Integrated genomic analysis of survival outliers in glioblastoma;Peng;Neuro Oncol.,2016

5. Differential predictors and clinical implications associated with long-term survivors in IDH wildtype and mutant glioblastoma;Jiang;Front. Oncol.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients;2024-09-08